The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

  • See Evidence submitted by expert panel for details.

Variant: NM_030662.3(MAP2K2):c.842G>A (p.Arg281Gln)

CA403385475

569590 (ClinVar)

Gene: MAP2K2
Condition: RASopathy
Inheritance Mode: Autosomal dominant inheritance
UUID: dfec0bf2-cccf-4932-8cf2-6dabf182615f
Approved on: 2020-03-19
Published on: 2020-03-23

HGVS expressions

NM_030662.3:c.842G>A
NM_030662.3(MAP2K2):c.842G>A (p.Arg281Gln)
NC_000019.10:g.4099278C>T
CM000681.2:g.4099278C>T
NC_000019.9:g.4099276C>T
CM000681.1:g.4099276C>T
NC_000019.8:g.4050276C>T
NG_007996.1:g.29851G>A
ENST00000394867.9:n.1281G>A
ENST00000687128.1:n.1281G>A
ENST00000688002.1:n.1136G>A
ENST00000689792.1:n.746G>A
ENST00000262948.10:c.842G>A
ENST00000262948.9:c.842G>A
ENST00000394867.8:c.551G>A
ENST00000593364.5:n.789G>A
ENST00000595715.1:n.657G>A
ENST00000597263.5:n.169+1741G>A
ENST00000599021.1:c.29+1741G>A
ENST00000600584.5:n.1402G>A
ENST00000601786.5:n.1143G>A
NM_030662.4:c.842G>A
More

Uncertain Significance

Met criteria codes 2
PP2 BP4
Not Met criteria codes 4
PM2 PM1 PM5 BS2

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
RASopathy VCEP
The c.842G>A (p.Arg281Gln) variant in MAP2K2 was present in 0.007324% (1/13654) of Latino chromosomes in gnomAD v3. It was observed in one healthy adult male who did not have features of a RASopathy (BS2 not met; Baylor internal data). The variant is located in the MAP2K2 gene, which has been defined by the ClinGen RASopathy Expert Panel as a gene with a low rate of benign missense variants and pathogenic variants are common (PP2; PMID: 29493581). Computational analysis and splice site predictors suggest that this variant does not impact the protein (BP4). In summary, the clinical significance of this variant is uncertain. RASopathy-specific ACMG/AMP criteria applied: PP2, BP4.
Met criteria codes
PP2
MAP2K2 is a missense-constrained gene.
BP4
REVEL score 0.032. May add a 3' splice site (predicted by SpliceSiteFinder-like and MaxEntScan but not NNSPLICE or GeneSplicer), however impact to splicing is not predicted to align with the GOF mechanism for MAP2K2-associated RASopathy. 1 animal in the UCSC database (guinea pig) has Q at this site.
Not Met criteria codes
PM2
Present in 0.007324% (1/13654) of Latino chromosomes in gnomAD v3. Absent from gnomAD v2.1.1.
PM1
Does not occur between aa 47-65 or 128-138.
PM5
Only 1 other variant in this codon, c.841C>T (p.Arg281Trp), has been reported. It was absent from ClinVar and was classified as a VUS by the EP.
BS2
This variant was seen in 3 unaffected individuals (Invitae internal data, SCV000817942.1; Baylor internal data). One case was a juvenile male tested because his father had idiopathic HCM, but the proband was supposedly unaffected and healthy. This case was not counted because the indication for testing was HCM. In 2 other cases, the variant was inherited and the fathers of the probands were noted to be asymptomatic. One proband was suspected to have NS; the other did not have a diagnosis.
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.